These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6315421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
    van Asbeck BS, Marcelis JH, Marx JJ, Struyvenberg A, van Kats JH, Verhoef J.
    Eur J Clin Microbiol; 1983 Oct; 2(5):426-31. PubMed ID: 6416837
    [Abstract] [Full Text] [Related]

  • 3. [Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
    Deguchi K, Fukayama S, Nishimura Y.
    Jpn J Antibiot; 1982 May; 35(5):1187-98. PubMed ID: 6290705
    [Abstract] [Full Text] [Related]

  • 4. The antibacterial activity of a siderophore. 3. The activity of deferoxamine in vitro and its influence on the effect of antibiotics against Escherichia coli, Proteus mirabilis and coagulase-negative staphylococci.
    Hartzen SH, Frimodt-Møller N, Thomsen VF.
    APMIS; 1994 Mar; 102(3):219-26. PubMed ID: 8185889
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The antibacterial activity of a siderophore. 2. The influence of deferoxamine alone and combined with ascorbic acid on the activity of antibiotics against Staphylococcus aureus.
    Hartzen SH, Frimodt-Møller N, Thomsen VF.
    APMIS; 1991 Oct; 99(10):879-86. PubMed ID: 1930961
    [Abstract] [Full Text] [Related]

  • 8. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H.
    Am J Med; 1986 Jun 30; 80(6B):126-37. PubMed ID: 3088998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The effect of gentamicin and other antibiotics on the pathogenic germs in urinary tract infections (author's transl)].
    Schmid W.
    Med Klin; 1973 Dec 14; 68(50):1652-6. PubMed ID: 4205807
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Resistance spectrum of various bacteria against cefotiam in 3 Berlin clinics].
    Hahn H, Wagner J.
    Immun Infekt; 1983 Jun 14; 11(4):140-2. PubMed ID: 6099820
    [Abstract] [Full Text] [Related]

  • 18. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Mar 14; 48(3):402-8. PubMed ID: 7752453
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
    Husson MO, Izard D, Leclerc H.
    Drugs Exp Clin Res; 1986 Mar 14; 12(4):325-7. PubMed ID: 3459642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.